Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial

NCT07368673 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Dow University of Health Sciences